Safety and efficacy of nivolumab and standard chemotherapy drug combination in patients with advanced non-small-cell lung cancer: a four arms phase Ib study
Kanda, S., Goto, K., Shiraishi, H., Kubo, E., Tanaka, A., Utsumi, H., Sunami, K., Kitazono, S., Mizugaki, H., Horinouchi, H., Fujiwara, Y., Nokihara, H., Yamamoto, N., Hozumi, H., Tamura, T.
Published in Annals of oncology (01.12.2016)
Published in Annals of oncology (01.12.2016)
Get full text
Journal Article
Randomized controlled trial of S-1 versus docetaxel in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy (East Asia S-1 Trial in Lung Cancer)
Nokihara, H., Lu, S., Mok, T.S.K., Nakagawa, K., Yamamoto, N., Shi, Y.K., Zhang, L., Soo, R.A., Yang, J.C., Sugawara, S., Nishio, M., Takahashi, T., Goto, K., Chang, J., Maemondo, M., Ichinose, Y., Cheng, Y., Lim, W.T., Morita, S., Tamura, T.
Published in Annals of oncology (01.11.2017)
Published in Annals of oncology (01.11.2017)
Get full text
Journal Article
Final overall survival analysis from the phase III J-ALEX study of alectinib versus crizotinib in ALK inhibitor-naïve Japanese patients with ALK-positive non-small-cell lung cancer
Hotta, K., Hida, T., Nokihara, H., Morise, M., Kim, Y.H., Azuma, K., Seto, T., Takiguchi, Y., Nishio, M., Yoshioka, H., Kumagai, T., Watanabe, S., Goto, K., Satouchi, M., Kozuki, T., Shukuya, T., Nakagawa, K., Mitsudomi, T., Yamamoto, N., Asakawa, T., Yoshimoto, T., Takata, S., Tamura, T.
Published in ESMO open (01.08.2022)
Published in ESMO open (01.08.2022)
Get full text
Journal Article
Phase I study of continuous afatinib (BIBW 2992) in patients with advanced non-small cell lung cancer after prior chemotherapy/erlotinib/gefitinib (LUX-Lung 4)
Murakami, H., Tamura, T., Takahashi, T., Nokihara, H., Naito, T., Nakamura, Y., Nishio, K., Seki, Y., Sarashina, A., Shahidi, M., Yamamoto, N.
Published in Cancer chemotherapy and pharmacology (01.04.2012)
Published in Cancer chemotherapy and pharmacology (01.04.2012)
Get full text
Journal Article
Phase 1 study of lenvatinib combined with carboplatin and paclitaxel in patients with non-small-cell lung cancer
NISHIO, M, HORAI, T, YUSA, W, KOYAMA, N, TAMURA, T, HORIIKE, A, NOKIHARA, H, YAMAMOTO, N, TAKAHASHI, T, MURAKAMI, H, YAMAMOTO, N, KOIZUMI, F, NISHIO, K
Published in British journal of cancer (06.08.2013)
Published in British journal of cancer (06.08.2013)
Get full text
Journal Article
A randomized, open-label, multicenter, phase 3 study to compare the efficacy and safety of eribulin to treatment of physician’s choice in patients with advanced non-small cell lung cancer
Katakami, N., Felip, E., Spigel, D.R., Kim, J.-H., Olivo, M., Guo, M., Nokihara, H., Yang, J. C.-H., Iannotti, N., Satouchi, M., Barlesi, F.
Published in Annals of oncology (01.09.2017)
Published in Annals of oncology (01.09.2017)
Get full text
Journal Article
Phase I study of LY2181308, an antisense oligonucleotide against survivin, in patients with advanced solid tumors
Tanioka, M., Nokihara, H., Yamamoto, N., Yamada, Y., Yamada, K., Goto, Y., Fujimoto, T., Sekiguchi, R., Uenaka, K., Callies, S., Tamura, T.
Published in Cancer chemotherapy and pharmacology (01.08.2011)
Published in Cancer chemotherapy and pharmacology (01.08.2011)
Get full text
Journal Article
Phase 2 study of lenvatinib in patients with RET fusion-positive adenocarcinoma of the lung
Velcheti, V, Hida, T, Reckamp, K.L, Yang, J.C, Nokihara, H, Sachdev, P, Feit, K, Kubota, T, Nakada, T, Dutcus, C.E, Ren, M, Tamura, T
Published in European journal of cancer (1990) (01.02.2017)
Published in European journal of cancer (1990) (01.02.2017)
Get full text
Journal Article
463 Multiplex detection of 17 kinds of oncogenic fusion and aberrant transcripts in formalin-fixed, paraffin embedded tissues of lung adenocarcinoma by molecular counting
Sunami, K, Furuta, K, Tsuta, K, Nakaoku, T, Shimada, Y, Watanabe, S.I, Nokihara, H, Sasada, S, Ohe, Y, Kohno, T
Published in European journal of cancer (1990) (01.09.2015)
Published in European journal of cancer (1990) (01.09.2015)
Get full text
Journal Article
Efficacy and Safety of Eribulin Compared with Treatment of Physician’s Choice (TPC) in Patients with Advanced Non-Small-Cell Lung Cancer (NSCLC): Results from a Phase 3 Study
Spigel, D.R, Barlesi, F, Felip, E, Kim, J, Olivo, M, Nokihara, H, Yang, J.C, Satouchi, M, Katakami, N, Iannotti, N
Published in International journal of radiation oncology, biology, physics (01.12.2014)
Published in International journal of radiation oncology, biology, physics (01.12.2014)
Get full text
Journal Article
9LBA Antitumor activity of ASP8273, an irreversible mutant selective EGFR-TKI, in NSCLC patients with tumors harboring EGFR activating mutations and T790M resistance mutation
Murakami, H, Nokihara, H, Shimizu, T, Seto, T, Keating, A, Krivoshik, A, Uegaki, K, Morita, S, Nakagawa, K, Fukuoka, M
Published in European journal of cancer (1990) (01.11.2014)
Published in European journal of cancer (1990) (01.11.2014)
Get full text
Journal Article
521 Phase II studies of Nivolumab in patients with Advanced Squamous (SQ) or Non-Squamous (NSQ) Non-Small Cell Lung Cancer (NSCLC)
Sakai, H, Nishio, M, Hida, T, Nakagawa, K, Nogami, N, Atagi, S, Takahashi, T, Nokihara, H, Saka, H, Takenoyama, M, Fujita, S, Tanaka, H, Takeda, K, Satouchi, M, Isobe, H, Maemondo, M, Goto, K, Hirashima, T, Minato, K, Tamura, T
Published in European journal of cancer (1990) (01.09.2015)
Published in European journal of cancer (1990) (01.09.2015)
Get full text
Journal Article
A phase II study of cisplatin and docetaxel administered as three consecutive weekly infusions for advanced non-small-cell lung cancer in elderly patients
Ohe, Y., Niho, S., Kakinuma, R., Kubota, K., Ohmatsu, H., Goto, K., Nokihara, H., Kunitoh, H., Saijo, N., Aono, H., Watanabe, K., Tango, M., Yokoyama, A., Nishiwaki, Y.
Published in Annals of oncology (01.01.2004)
Published in Annals of oncology (01.01.2004)
Get full text
Journal Article
Characteristics and outcomes of patients with advanced non-small-cell lung cancer who declined to participate in randomised clinical chemotherapy trials
LANAI, C, NOKIHARA, H, YAMAMOTO, S, KUNITOH, H, YAMAMOTO, N, SEKINE, I, OHE, Y, TAMURA, T
Published in British journal of cancer (07.04.2009)
Published in British journal of cancer (07.04.2009)
Get full text
Journal Article
Gender difference in hematological toxicity among lung cancer patients receiving amrubicin monotherapy
Makihara, Reiko Ando, Makino, Yoshinori, Yamamoto, Noboru, Yokote, Nobuaki, Nokihara, Hiroshi, Sekine, Ikuo, Ohe, Yuichiro, Tamura, Tomohide, Yamamoto, Hiroshi
Published in Japanese journal of clinical oncology (01.12.2012)
Published in Japanese journal of clinical oncology (01.12.2012)
Get full text
Journal Article
Multi-institutional phase II trial of irinotecan, cisplatin, and etoposide for sensitive relapsed small-cell lung cancer
GOTO, K, SEKINE, I, TAMURA, T, OHE, Y, KUNITOH, H, YAMAMOTO, N, NOKIHARA, H, YOSHIDA, K, SUGIURA, T, MATSUI, K, SAIJO, N, NISHIWAKI, Y, KAKINUMA, R, KUBOTA, K, MATSUMOTO, T, OHMATSU, H, NIHO, S, KODAMA, T, SHINKAI, T
Published in British journal of cancer (16.08.2004)
Published in British journal of cancer (16.08.2004)
Get full text
Journal Article
Randomised phase II trial of irinotecan plus cisplatin vs irinotecan, cisplatin plus etoposide repeated every 3 weeks in patients with extensive-disease small-cell lung cancer
SEKINE, I, NOKIHARA, H, TAKEDA, K, NISHIWAKI, Y, NAKAGAWA, K, ISOBE, H, MORI, K, MATSUI, K, SAIJO, N, TAMURA, T
Published in British journal of cancer (26.02.2008)
Published in British journal of cancer (26.02.2008)
Get full text
Journal Article
Phase I study of cisplatin analogue nedaplatin (254-S) and paclitaxel in patients with unresectable squamous cell carcinoma
SEKINE, I, NOKIHARA, H, HORIIKE, A, YAMAMOTO, N, KUNITOH, H, OHE, Y, TAMURA, T, KODAMA, T, SAIJO, N
Published in British journal of cancer (22.03.2004)
Published in British journal of cancer (22.03.2004)
Get full text
Journal Article
415 A phase I study evaluating the safety profile and pharmacokinetics of CS-1008 (Tigatuzumab), humanized monoclonal antibody targeting death receptor 5 (DR5), in Japanese patients with advanced solid tumours
Nokihara, H, Yamamoto, N, Yamada, Y, Asahina, H, Shibata, T, Seki, Y, Tamura, Y, Honda, K, Misawa, S, Tamura, T
Published in European journal of cancer supplements (2010)
Published in European journal of cancer supplements (2010)
Get full text
Journal Article
1321P Real-world treatments and clinical outcomes in advanced NSCLC without actionable mutations after introduction of immunotherapy (IO) in Japan
Nokihara, H., Santorelli, M.L., Taniguchi, K., Kamitani, T., Irisawa, M., Kanda, K., Abe, M., Burke, T., Goto, Y.
Published in Annals of oncology (01.09.2021)
Published in Annals of oncology (01.09.2021)
Get full text
Journal Article